News – Page 355 – Endpoints News

BioMarin makes $41M+ expansion to Irish facility

3 years ago

European pharma overhaul draft is coming Wednesday: Here's what's expected

3 years ago

Boehringer Ingelheim kicks off €350M R&D center in Germany

3 years ago

Applied Therapeutics says rare disease drug fails PhIII trial, still plans to seek approval

3 years ago

4D Molecular Therapeutics acquires eye disease asset from Fortress Biotech subsidiary

3 years ago

Aurinia shareholder calls for sale talks, nixes support for CEO and chair

3 years ago

Lilly will test its weight loss drug directly against Novo Nordisk's Wegovy

3 years ago

On Vertex and CRISPR Therapeutics’ heels, bluebird submits sickle cell gene therapy to FDA

3 years ago

FDA puts second Foghorn study on partial hold after serious heart event

3 years ago

FDA lifts nearly two-year hold on MaaT Pharma's microbiome therapy, opens door to PhIII

3 years ago

Lilly divests low blood sugar rescue treatment for $500M as industry focuses on dealmaking

3 years ago

Unity touts PhII win, plots head-to-head with Regeneron drug in 'defining moment'

3 years ago

A ‘blistering’ start to M&A in 2023 stokes hopes of a market rebound, as insiders predict a surge in deals

3 years ago

AstraZeneca, Ionis unveil full PhIII data for 'mega brand' ATTR drug

3 years ago

Merck’s $10.8B Prometheus buyout, GSK’s $2B Bellus takeover fuel M&A buzz; CAR-T data leak; Best of #AACR23; and ...

3 years ago

Supreme Court preserves access to abortion pill as court cases play out

3 years ago

FDA gives approval to Novartis' manufacturing site for Pluvicto

3 years ago

Serum Institute of India in talks to secure a fill-finish deal for the Oxford malaria vaccine in Ghana

3 years ago

How not to run a single-arm trial: EMA highlights more than a dozen 'biases' — and ways to mitigate them

3 years ago

Apellis’ expansion plans into ALS face roadblock

3 years ago

Lilly, Novo Nordisk, Sanofi CEOs to face off with Bernie Sanders' health committee in May

3 years ago

Roche’s Genentech debuts first consumer effort for diabetes and age-related eye disease drug

3 years ago

SK Life Science sets up an indoor rainstorm to point to its anti-seizure drug Xcopri's full coverage

3 years ago

'We want to carry them all': Mark Cuban on why transparency is king when it comes to drug prices

3 years ago

First page Previous page 352 353 354355356 357 358 Next page Last page